SMTL ID : 9r59.1

Crystal structure of MAPKAPK2 with a covalent compound GCL334 targeting lysine

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.00 Å

Oligo State

monomer

Ligands

1 x 01: 5-[3-[bis(oxidanyl)-$l^{3}-sulfanyl]oxy-4-chloranyl-phenyl]-~{N}-(4-piperazin-1-ylphenyl)-~{N}-(pyridin-2-ylmethyl)furan-2-carboxamide

01.1: 15 residues within 4Å: Chain A: V.34, L.35, Q.36, A.47, K.49, M.94, E.95, C.96, L.97, D.98, E.101, E.146, L.149, T.162, D.163 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:V.34, A:Q.36, A:A.47, A:L.97, A:L.97, A:L.149 Hydrogen bonds: A:L.97, A:D.163, A:D.163 Salt bridges: A:D.163 Halogen bonds: A:D.163

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hillebrand, L. et al., A twist in the tale: shifting from covalent targeting of a tyrosine in JAK3 to a lysine in MK2. Rsc Med Chem (2025)

Release Date

2025-07-30

Peptides

MAP kinase-activated protein kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

MAP kinase-activated protein kinase 2